Tianjin Ringpu Bio-Technology Co.,Ltd.

SZSE:300119 Stock Report

Market Cap: CN¥8.8b

Tianjin Ringpu Bio-TechnologyLtd Management

Management criteria checks 3/4

Tianjin Ringpu Bio-TechnologyLtd's CEO is Lei Xu, appointed in Mar 2023, has a tenure of 1.67 years. directly owns 0.047% of the company’s shares, worth CN¥4.16M. The average tenure of the management team and the board of directors is 2.2 years and 2.2 years respectively.

Key information

Lei Xu

Chief executive officer

CN¥1.2m

Total compensation

CEO salary percentagen/a
CEO tenure1.7yrs
CEO ownership0.05%
Management average tenure2.2yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

Solid Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)

Nov 05
Solid Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)

These 4 Measures Indicate That Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Is Using Debt Reasonably Well

Oct 30
These 4 Measures Indicate That Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Is Using Debt Reasonably Well

The Market Lifts Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares 36% But It Can Do More

Oct 08
The Market Lifts Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares 36% But It Can Do More

Tianjin Ringpu Bio-Technology Co.,Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Aug 26
Tianjin Ringpu Bio-Technology Co.,Ltd. Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected

Improved Earnings Required Before Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares Find Their Feet

Aug 23
Improved Earnings Required Before Tianjin Ringpu Bio-Technology Co.,Ltd. (SZSE:300119) Shares Find Their Feet

Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Seems To Use Debt Quite Sensibly

Jun 26
Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119) Seems To Use Debt Quite Sensibly

Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)

Apr 05
Impressive Earnings May Not Tell The Whole Story For Tianjin Ringpu Bio-TechnologyLtd (SZSE:300119)

Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Subdued P/E Might Signal An Opportunity

Mar 28
Tianjin Ringpu Bio-Technology Co.,Ltd.'s (SZSE:300119) Subdued P/E Might Signal An Opportunity

CEO

Lei Xu (51 yo)

1.7yrs

Tenure

CN¥1,169,300

Compensation

Mr. Lei Xu serves as General Manager since March 30, 2023 and Non-Independent Director of Tianjin Ringpu Bio-Technology Co.,Ltd. Since September 13, 2022. He served as Director and Deputy General Manager a...


Leadership Team

NamePositionTenureCompensationOwnership
Lei Xu
GM & Director1.7yrsCN¥1.17m0.047%
CN¥ 4.2m
Gaibian Li
Financial Manager2.6yrsCN¥459.60k0.0032%
CN¥ 286.4k
Ailing Liu
Deputy GM & Directorno dataCN¥1.01m0.034%
CN¥ 3.0m
Xiutong Zhu
Non-Independent Director & Deputy GMno dataCN¥780.20k0.021%
CN¥ 1.9m
Gang Xie
Board Secretary2.3yrsCN¥644.90kno data
Yongjun You
Deputy General Manager2.2yrsCN¥1.13m0.034%
CN¥ 3.0m
Endong Bao
Chief Inspector of Technology Centreno datano data2.42%
CN¥ 213.4m

2.2yrs

Average Tenure

49yo

Average Age

Experienced Management: 300119's management team is considered experienced (2.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Lei Xu
GM & Director2.2yrsCN¥1.17m0.047%
CN¥ 4.2m
Ailing Liu
Deputy GM & Director5.9yrsCN¥1.01m0.034%
CN¥ 3.0m
Xiutong Zhu
Non-Independent Director & Deputy GM2.2yrsCN¥780.20k0.021%
CN¥ 1.9m
Shoujun Li
Chairman16.5yrsCN¥1.58m36.32%
CN¥ 3.2b
Rui Li
Director5.9yrsCN¥402.50k0.0026%
CN¥ 229.1k
Jing Yang
Non-Independent Director2.2yrsCN¥100.00k0.0033%
CN¥ 292.5k
Chunlin Guo
Independent Director2.2yrsCN¥100.00kno data
Xuepeng Cai
Independent Director2.2yrsno datano data
Rui Zhou
Independent Director2.2yrsCN¥100.00kno data
Zhonghua Zhou
Chairman of the Supervisory Board2.2yrsno data1.12%
CN¥ 99.1m
Fei Liang
Supervisor1.7yrsno datano data

2.2yrs

Average Tenure

51yo

Average Age

Experienced Board: 300119's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.